AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 102 filers reported holding AEGERION PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $15,000 | +114.3% | 4,926 | 0.0% | 0.00% | – |
Q2 2016 | $7,000 | -97.9% | 4,926 | -94.6% | 0.00% | – |
Q1 2016 | $338,000 | -62.7% | 91,344 | +1.8% | 0.00% | -100.0% |
Q4 2015 | $906,000 | -25.4% | 89,730 | +0.4% | 0.00% | -50.0% |
Q3 2015 | $1,215,000 | -28.8% | 89,331 | -0.7% | 0.00% | 0.0% |
Q2 2015 | $1,707,000 | -20.0% | 89,978 | +10.4% | 0.00% | -33.3% |
Q1 2015 | $2,134,000 | +25.8% | 81,534 | +0.7% | 0.00% | +50.0% |
Q4 2014 | $1,696,000 | -37.5% | 80,982 | -0.3% | 0.00% | -50.0% |
Q3 2014 | $2,712,000 | +4.8% | 81,247 | +0.8% | 0.00% | +33.3% |
Q2 2014 | $2,588,000 | -29.6% | 80,640 | +1.3% | 0.00% | -40.0% |
Q1 2014 | $3,676,000 | -34.6% | 79,609 | +0.5% | 0.01% | -37.5% |
Q4 2013 | $5,622,000 | -19.2% | 79,233 | -2.4% | 0.01% | -27.3% |
Q3 2013 | $6,962,000 | +43.8% | 81,184 | +6.2% | 0.01% | +22.2% |
Q2 2013 | $4,840,000 | – | 76,411 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 4,656,682 | $399,310,000 | 16.44% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,300,000 | $111,475,000 | 5.48% |
ADVENT INTERNATIONAL, L.P. | 705,300 | $60,479,000 | 5.01% |
Antipodean Advisors LLC | 266,400 | $22,844,000 | 2.38% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 489,181 | $41,928,000 | 2.06% |
HealthCor Management, L.P. | 425,000 | $36,444,000 | 1.95% |
Cupps Capital Management, LLC | 290,489 | $24,909,000 | 1.62% |
Zweig-DiMenna Associates LLC | 421,400 | $36,135,000 | 1.46% |
SABBY MANAGEMENT, LLC | 259,119 | $22,209,000 | 1.44% |
Independence Capital Asset Partners, LLC | 98,070 | $8,410,000 | 1.43% |